Home › Markets › Health Care › MDT

Medtronic plc. (MDT)

MDT trades on NYSE in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$93.01
+1.18% on the day
Market cap
$119.0B
Large cap
Revenue · 2025
$36.4B
+8.4% on 2024
Net income · 2025
$5K
0.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerMDT on NYSE
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001613103
SEC industry codeElectromedical & Electrotherapeutic Apparatus

Financials · 2025

LineValue
Revenue$36.4B
Net income$5K
Operating income$6.5B
Net margin0.0%
Operating margin17.8%
Revenue growth+8.4%
Cash$1.1B
Total assets$91.5B
P/E (computed)24780798.8×
P/S (computed)3.3×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-03-09
Latest annual report10-K2026-06-18
Latest quarterly / interim10-Q2026-09-03
Latest current report8-K2026-09-17
Latest proxyDEFA14A2026-08-17

Source: SEC EDGAR submissions feed, 1,008 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+9.5%
1 month-0.1%
3 months+12.0%
Year to date-2.5%
1 year-2.0%
From 52-week high-11.1%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
ITGRInteger Holdings Corporation$126.59+0.06%$4.3B
LIVNLivaNova PLC$76.37-1.17%$4.2B
TMDXTransMedics Group Inc.$79.14+1.23%$2.7B
AXGNAxogen Inc.$36.17-2.53%$2.1B
CNMDCONMED Corporation$45.55+0.42%$1.4B
CBLLCeriBell Inc.$26.14+3.48%$1.0B
INMDInMode Ltd.$14.30+0.04%$822.3M
CVCapsoVision Inc.$6.78+0.30%$360.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier